Man Group’s AstraZeneca AZN Stock Holding History

Man Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$128M	Buy	683,112 +54,636	+9%	+$10.3M	0.2%	108
2026 Q1	$122M	Buy	+628,476	New	+$121M	0.22%	106
2018 Q2	–	Sell	-94,661	Closed	-$6.62M	–	2112
2018 Q1	$6.62M	Buy	+94,661	New	+$6.56M	0.03%	704

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Man Group's AZN Position: Q2 2026 in Review

Man Group increased its AstraZeneca (AZN) stake by 8.7% in Q2 2026, buying an estimated $10.3M and bringing the position to 683,112 shares worth $128M. The position accounts for 0.2% of the portfolio, ranked #108.

Man Group first reported a position in AZN in Q1 2018 and has held it in 3 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Man Group held 683,112 shares of AstraZeneca worth $128M as of Q2 2026.
Man Group bought 54,636 AstraZeneca shares in Q2 2026, an estimated $10.3M.
AstraZeneca made up 0.2% of Man Group's portfolio in Q2 2026, its #108 holding.
Man Group first reported a position in AstraZeneca in Q1 2018 and has held it in 3 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.